Lupus & antiphospholipid syndrome

Factors associated with poor outcomes in systemic lupus erythematosus (SLE) patients with COVID-19: Data from ReumaCoV-Brazil register

LupusPublished Cross-sectional analysis of baseline data of the ReumaCoV Brazil prospective cohort study

Authors' conclusion

Hypertension and cyclophosphamide were associated with a severe outcome, and telemedicine can be a useful tool for SLE patients with COVID-19.

Study context

Population
Adult SLE patients in the ReumaCoV Brazil register during the SARS-CoV-2 pandemic
Participants
604 patients
Exposure
SLE patients with COVID-19 vs SLE patients without COVID-19
  • COVID-19n = 317
  • Controln = 287reference
Outcome
Factors associated with COVID-19 severity outcomes (hospitalization related to COVID-19)
Methodological detailsprospective, multi-stage cohort
  • Prospective, multi-stage cohort

Main finding

As reported in the abstract

Factors independently associated with hospitalization related to COVID-19
Odds ratio (95% CI)P value
Arterial hypertension
2.48(1.04–5.91)
P = 0.041
Cyclophosphamide
14.32(2.12–96.77)
P = 0.006
Dyspnea
7.10(3.10–16.23)
P < 0.001
Telemedicine support67% lower chance of hospitalization
0.33(0.12–0.88)
P = 0.02
Discontinuation of SLE treatment during infection
5.38 (95% CI 1.97–15.48); P = 0.002

Observational data: associations, not effects.

Further findings

OutcomeCOVID-19ControlP value
SLEDAI-2K score, post-COVID-19 periodNo difference between groupsmean 5.8 (unspecified (bracketed) 8.6)mean 4.5 (unspecified (bracketed) 8.0)P = 0.190
SLE activity by PGA, post-COVID-19 periodInfected patients reported increased SLE activity2.9 (unspecified (bracketed) 2.9)— withheld: not confirmed against the abstractP = 0.031

— withheld: the automatic checks could not confirm the value against the abstract

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register. Lupus. Published 27 October 2022. doi:10.1177/09612033221135884

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.